Stoke Therapeutics Inc (STOK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -52,069 | -26,374 | -104,699 | -77,741 | -53,199 |
| Depreciation Amortization | 798 | 539 | 2,144 | 1,609 | 1,094 |
| Other Working Capital | -4,721 | -4,691 | -6,030 | -5,155 | -4,804 |
| Other Operating Activity | 13,949 | 5,960 | 27,518 | 20,869 | 13,753 |
| Operating Cash Flow | $-42,043 | $-24,566 | $-81,067 | $-60,418 | $-43,156 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -58 | -12 | -1,616 | -1,387 | -1,004 |
| Purchase Of Investment | -88,232 | N/A | N/A | N/A | N/A |
| Sale Of Investment | 10,000 | 10,000 | 107,562 | 92,562 | 77,562 |
| Investing Cash Flow | $-78,290 | $9,988 | $105,946 | $91,175 | $76,558 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 122,199 | 1,549 | 52,452 | 45,664 | 44,896 |
| Other Financing Activity | 168 | 168 | 555 | 0 | 206 |
| Financing Cash Flow | $122,367 | $1,717 | $53,007 | $45,664 | $45,102 |
| Beginning Cash Position | 192,011 | 192,011 | 114,125 | 114,125 | 114,125 |
| End Cash Position | 194,045 | 179,150 | 192,011 | 190,546 | 192,629 |
| Net Cash Flow | $2,034 | $-12,861 | $77,886 | $76,421 | $78,504 |
| Free Cash Flow | |||||
| Operating Cash Flow | -42,043 | -24,566 | -81,067 | -60,418 | -43,156 |
| Capital Expenditure | -58 | -12 | -1,616 | -1,387 | -1,004 |
| Free Cash Flow | -42,101 | -24,578 | -82,683 | -61,805 | -44,160 |